Evidence map›Paper›PMID 36252012›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

The ulcerative colitis-associated gene FUT8 regulates the quantity and quality of secreted mucins.

Gerard Cantero-Recasens, Carla Burballa, Yuki Ohkawa, Tomohiko Fukuda, Yoichiro Harada, IBD Character Consortium, Amy J Curwin, Nathalie Brouwers, Gian A Thun, Jianguo Gu and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Gerard Cantero-RecasensCentre for Genomic Regulation, The Barcelona Institute for Science and Technology, 08003 Barcelona, Spain.ORCID 0000-0001-6452-782X
Carla BurballaCentre for Genomic Regulation, The Barcelona Institute for Science and Technology, 08003 Barcelona, Spain.ORCID 0000-0002-0091-1459
Yuki OhkawaDepartment of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Osaka 541-8567, Japan.ORCID 0000-0002-8314-0855
Tomohiko FukudaDivision of Regulatory Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Miyagi 981-8558, Japan.
Yoichiro HaradaDepartment of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Osaka 541-8567, Japan.
IBD Character Consortium
Amy J CurwinCentre for Genomic Regulation, The Barcelona Institute for Science and Technology, 08003 Barcelona, Spain.ORCID 0000-0003-1086-2483
Nathalie BrouwersCentre for Genomic Regulation, The Barcelona Institute for Science and Technology, 08003 Barcelona, Spain.
Gian A ThunCNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, 08028 Spain.ORCID 0000-0003-4436-3455
Jianguo GuDivision of Regulatory Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Miyagi 981-8558, Japan.ORCID 0000-0003-0241-8788
Ivo GutCNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, 08028 Spain.
Naoyuki TaniguchiDepartment of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Osaka 541-8567, Japan.ORCID 0000-0001-5889-5968
Vivek MalhotraCentre for Genomic Regulation, The Barcelona Institute for Science and Technology, 08003 Barcelona, Spain.
Osaka International Cancer Institute · JPBarcelona Institute of Science and Technology · ESCentre for Genomic Regulation · ESTohoku Medical and Pharmaceutical University · JPVall d'Hebron Institut de Recerca · ESInstitució Catalana de Recerca i Estudis Avançats · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucins are the main macrocomponents of the mucus layer that protects the digestive tract from pathogens. Fucosylation of mucins increases mucus viscoelasticity and its resistance to shear stress. These properties are altered in patients with ulcerative colitis (UC), which is marked by a chronic inflammation of the distal part of the colon. Here, we show that levels of Fucosyltransferase 8 (FUT8) and specific mucins are increased in the distal inflamed colon of UC patients. Recapitulating this FUT8 overexpression in mucin-producing HT29-18N2 colonic cell line increases delivery of MUC1 to the plasma membrane and extracellular release of MUC2 and MUC5AC. Mucins secreted by FUT8 overexpressing cells are more resistant to removal from the cell surface than mucins secreted by FUT8-depleted cells (FUT8 KD). FUT8 KD causes intracellular accumulation of MUC1 and alters the ratio of secreted MUC2 to MUC5AC. These data fit well with the

Indexed as

Colitis, UlcerativeFucosyltransferasesAnimalsHT29 CellsInflammationMiceMucin-2FucosyltransferasesGlycoprotein 6-alpha-L-fucosyltransferaseMucin-2fucosylationFUT8mucin secretionulcerative colitis

Identifiers

PMID36252012
PMCPMC9618082
OpenAlexW4306642651

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.